JPWO2024257775A1 - - Google Patents
Info
- Publication number
- JPWO2024257775A1 JPWO2024257775A1 JP2025519185A JP2025519185A JPWO2024257775A1 JP WO2024257775 A1 JPWO2024257775 A1 JP WO2024257775A1 JP 2025519185 A JP2025519185 A JP 2025519185A JP 2025519185 A JP2025519185 A JP 2025519185A JP WO2024257775 A1 JPWO2024257775 A1 JP WO2024257775A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/84—Sulfur atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Toxicology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023098209 | 2023-06-15 | ||
| JP2023098209 | 2023-06-15 | ||
| PCT/JP2024/021265 WO2024257775A1 (ja) | 2023-06-15 | 2024-06-12 | 化合物又はその塩及びその製造方法、組成物、過酸化水素除去剤、並びに、細胞毒性抑制剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JPWO2024257775A1 true JPWO2024257775A1 (https=) | 2024-12-19 |
| JPWO2024257775A5 JPWO2024257775A5 (https=) | 2025-06-12 |
| JP7755772B2 JP7755772B2 (ja) | 2025-10-16 |
Family
ID=93852144
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025519185A Active JP7755772B2 (ja) | 2023-06-15 | 2024-06-12 | 化合物又はその塩及びその製造方法、組成物、過酸化水素除去剤、並びに、細胞毒性抑制剤 |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP4729511A1 (https=) |
| JP (1) | JP7755772B2 (https=) |
| KR (1) | KR20260022421A (https=) |
| CN (1) | CN121311472A (https=) |
| WO (1) | WO2024257775A1 (https=) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007300916A (ja) * | 2006-04-10 | 2007-11-22 | Manabu Nukina | エルゴチオネインの製造方法 |
| CN109091422A (zh) * | 2018-08-01 | 2018-12-28 | 上海应用技术大学 | 含榆黄菇提取液的化妆品及其制备方法 |
| CN109293572A (zh) * | 2018-09-26 | 2019-02-01 | 上海市农业科学院 | 一种提取榆黄菇中麦角硫因与多糖的方法 |
| WO2021177397A1 (ja) * | 2020-03-04 | 2021-09-10 | 長瀬産業株式会社 | Ｌ－エルゴチオネイン含有組成物 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008156320A (ja) | 2006-12-26 | 2008-07-10 | Hydrox Kk | 抗酸化性機能水 |
| JP2020103100A (ja) | 2018-12-27 | 2020-07-09 | 小林製薬株式会社 | 細胞内の抗酸化機能亢進剤 |
-
2024
- 2024-06-12 CN CN202480039105.XA patent/CN121311472A/zh active Pending
- 2024-06-12 JP JP2025519185A patent/JP7755772B2/ja active Active
- 2024-06-12 KR KR1020267000808A patent/KR20260022421A/ko active Pending
- 2024-06-12 EP EP24823390.0A patent/EP4729511A1/en active Pending
- 2024-06-12 WO PCT/JP2024/021265 patent/WO2024257775A1/ja not_active Ceased
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007300916A (ja) * | 2006-04-10 | 2007-11-22 | Manabu Nukina | エルゴチオネインの製造方法 |
| CN109091422A (zh) * | 2018-08-01 | 2018-12-28 | 上海应用技术大学 | 含榆黄菇提取液的化妆品及其制备方法 |
| CN109293572A (zh) * | 2018-09-26 | 2019-02-01 | 上海市农业科学院 | 一种提取榆黄菇中麦角硫因与多糖的方法 |
| WO2021177397A1 (ja) * | 2020-03-04 | 2021-09-10 | 長瀬産業株式会社 | Ｌ－エルゴチオネイン含有組成物 |
Non-Patent Citations (1)
| Title |
|---|
| SERVILLO, L. ET AL.: "An uncommon redox behavior sheds light on the cellular antioxidant properties of ergothioneine", FREE RADICAL BIOLOGY & MEDICINE, vol. 79, JPN6024032811, 2015, pages 228 - 236, ISSN: 0005626660 * |
Also Published As
| Publication number | Publication date |
|---|---|
| JP7755772B2 (ja) | 2025-10-16 |
| WO2024257775A1 (ja) | 2024-12-19 |
| EP4729511A1 (en) | 2026-04-22 |
| KR20260022421A (ko) | 2026-02-19 |
| CN121311472A (zh) | 2026-01-09 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20250402 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20250402 |
|
| A871 | Explanation of circumstances concerning accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A871 Effective date: 20250402 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20250624 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20250825 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20250911 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20251002 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20251003 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7755772 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |